BioNexus Gene Lab (BGLC) vs CitroTech (CITR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
CitroTech is the larger company by market cap ($66.6 million vs $3.7 million), about 18.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BGLC | CITR |
|---|---|---|
| Share price | $1.25 | $2.93 |
| Market cap | $3.66M | $66.56M |
| 1-day change | -7.24% | +1.03% |
| YTD return | — | -63.74% |
| EPS (TTM) | $-1.26 | $-2.73 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.89 | $10.37 |
| 52-week low | $1.07 | $2.65 |
| Distance from 52-week high | -78.78% | -71.75% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +446.08% |
| Average volume | 11.02K | 40.09K |
| Shares outstanding | 2.93M | 22.72M |
| Employees | 19 | 14 |
| Sector | Health Care | Industrials |
| Industry | Medical Specialities | Major Chemicals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CitroTech is about 18.2 times larger than BioNexus Gene Lab by market value ($66.56M vs $3.66M).
- The two companies sit in different sectors: BioNexus Gene Lab in Health Care and CitroTech in Industrials.
About BioNexus Gene Lab
BGLC stock →BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding.
Health Care · Medical Specialities · 19 employees
About CitroTech
CITR stock →CitroTech Inc. manufactures and sells fire inhibitor products in the United States and Canada.
Industrials · Major Chemicals · 14 employees
BGLC vs CITR FAQ
Which is bigger, BioNexus Gene Lab or CitroTech?
CitroTech (CITR) is larger, with a market capitalization of $66.56M compared with $3.66M for BioNexus Gene Lab (BGLC).
Are BioNexus Gene Lab and CitroTech in the same industry?
No. BioNexus Gene Lab is in the Health Care sector, while CitroTech is in Industrials.